• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
Classification Nameneuromodulator for obesity
Generic Nameneuromodulator for obesity
2800 patton road
saint paul, MN 55113
PMA NumberP130019
Date Received06/21/2013
Decision Date01/14/2015
Product Code
PIM[ Registered Establishments with PIM ]
Docket Number 15M-0201
Notice Date 01/16/2015
Advisory Committee Gastroenterology/Urology
Clinical Trials NCT01327976
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the maestro® rechargeable system. This device is indicated for use in weight reduction in patients aged 18 years through adulthood who have a body mass index (bmi) of 40 to 45 kg/m2, or a bmi of 35 to 39. 9 kg/m2 with one or more obesity related co-morbid conditions, and have failed at least one supervised weight management program within the past five years.
Approval Order Approval Order
Summary Summary of Safety and Effectiveness
Labeling Labeling
Post-Approval StudyShow Report Schedule and Study Progress
Supplements: S001 S002 S003 S004 S005 S006 S007 S008 S009 
S010 S011